Pages that link to "Q40021835"

The following pages link to G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress. (Q40021835):

Displaying 18 items.

• Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy (Q21245716) (← links)
• Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia (Q28478143) (← links)
• p38 mitogen-activated protein kinase promotes cell survival in response to DNA damage but is not required for the G(2) DNA damage checkpoint in human cancer cells (Q34045669) (← links)
• UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines (Q34640744) (← links)
• Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype (Q36009717) (← links)
• Cell cycle control in acute myeloid leukemia. (Q36206479) (← links)
• CDC25 Inhibition in Acute Myeloid Leukemia-A Study of Patient Heterogeneity and the Effects of Different Inhibitors (Q36305952) (← links)
• Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2. (Q37164205) (← links)
• Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy (Q37736274) (← links)
• Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms. (Q38268221) (← links)
• Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia (Q39142229) (← links)
• DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1. (Q39695043) (← links)
• USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation. (Q42729257) (← links)
• A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells (Q43071124) (← links)
• Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect (Q43461214) (← links)
• Roles of 14-3-3η in mitotic progression and its potential use as a therapeutic target for cancers (Q45241737) (← links)
• The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. (Q53295548) (← links)
• A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia (Q58414303) (← links)